Search results
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Is Novavax Stock A Buy After Winning A Key Designation From The World Health Organization?
Investor's Business Daily· 3 months agoNovavax stock remained bound under its key moving averages in January 2024 despite winning numerous...
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
Zacks via Yahoo Finance· 9 months agoNovavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat...
Why Novavax (NVAX) Stock Was Down 13% on Thursday
Zacks via Yahoo Finance· 2 years agoShares of Novavax, Inc. NVAX dropped 13.3% on Sep 22 after analysts at JP Morgan recently downgraded the stock’s recommendation from Neutral to...
Owning 48% shares,institutional owners seem interested in Novavax, Inc. (NASDAQ:NVAX),
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significantly high institutional ownership implies Novavax's stock price is sensitive...
These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts
Simply Wall St. via Yahoo Finance· 2 years agoThe latest analyst coverage could presage a bad day for Novavax, Inc. (NASDAQ:NVAX), with the...
Novavax, Inc. (NASDAQ:NVAX) Shares Fly 54% But Investors Aren't Buying For Growth
Simply Wall St. via Yahoo Finance· 1 year agoNovavax, Inc. (NASDAQ:NVAX) shareholders are no doubt pleased to see that the share price has...
Novavax, Inc. (NASDAQ:NVAX) surges 16%; individual investors who own 57% shares profited along with...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Novavax, Inc. (NASDAQ:NVAX) should be aware of the most powerful shareholder...
Why Novavax Stock Hit a Fresh 52-Week Low Today
Motley Fool· 2 years agoShares of the recombinant-protein vaccine specialist Novavax (NASDAQ: NVAX) were down by a noteworthy 9.2% on heavy volume as of 9:55 a.m. ET on...
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
Motley Fool· 6 months agoNovavax (NASDAQ: NVAX) is facing some significant headwinds. Its financials aren't in great shape,...